MedTrace Logo

Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.

NCT07263984 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2025-12-04

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the added value of three-dimensional transvaginal ultrasound (3D TVUS) and gel infusion sonography (3D GIS) for diagnosing a partition in the uterus (uterine septum) in comparison to magnetic resonance imaging (MRI). The main question it aims to answer is:

How well do 3D TVUS and 3D GIS detect a uterine septum compared to MRI?

Participants will receive 3D TVUS/ 3D GIS and MRI, and will complete questionnaires.

Conditions

  • Uterine Septum

Interventions

DIAGNOSTIC_TEST

Magnetic Resonance Imaging

MRI of the pelvis

DIAGNOSTIC_TEST

Three-dimensional transvaginal ultrasound

Three-dimensional transvaginal ultrasound

DIAGNOSTIC_TEST

Three-dimensional transvaginal Gel Infusion Sonography

Three-dimensional transvaginal Gel Infusion Sonography

OTHER

Questionnaires

Questionnaires

Sponsors & Collaborators

  • Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)

    collaborator OTHER

  • University Hospital, Ghent

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-27
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07263984 on ClinicalTrials.gov